Meetings - The ASCO Post

Cara Norelli, MS, AGNP-C, of Memorial Sloan Kettering Cancer Center, discusses her presentation on dermatologic toxicities seen in patients with cancer from the JADPRO Live conference recently held in...

breast cancer

By The ASCO Post Staff / 2024 JADPRO Live

Kathryn Newlin, RN, MSN, ANP-BC, on Updates in HR-Positive, HER2-Negative Metastatic Breast Cancer

Kathryn Newlin, RN, MSN, ANP-BC, of Washington University in St. Louis, discusses her presentation on HR+ HER2- metastatic breast cancer from the JADPRO Live conference recently held in Grapevine, Tex...

solid tumors

hematologic malignancies

By The ASCO Post Staff / 2024 JADPRO Live

Justin Arnall, PharmD, BCOP, FCCP, on Complicating “Factors”: When Malignancy and Non-Malignant Hematology Collide

Justin Arnall, PharmD, BCOP, FCCP, of Atrium Health Specialty Pharmacy Service in Charlotte, North Carolina, discusses his JADPRO Live presentation on critical considerations when planning for cancer-...

2024 JADPRO Live

Cara Norelli, MS, AGNP-C, on Managing Dermatologic Side Effects in Patients With Cancer

Kathryn Newlin, RN, MSN, ANP-BC, on Updates in HR-Positive, HER2-Negative Metastatic Breast Cancer

Justin Arnall, PharmD, BCOP, FCCP, on Complicating “Factors”: When Malignancy and Non-Malignant Hematology Collide

Risk-Reducing Surgeries Improve Survival for Younger Patients With Breast Cancer Who Are BRCA Carriers, Study Finds

HRQOL With Endocrine Therapy vs Radiotherapy After Breast-Conserving Surgery in Older Women With Luminal A–Like Early Breast Cancer

RELATIVITY-047 Extended Analysis of Overall Survival With Nivolumab-Relatlimab vs Nivolumab in Previously Untreated Advanced Melanoma

Psilocybin Based Therapy May Address Mental Health Issues in Patients With Cancer Addiction

Advanced Imaging May Uncover Hidden Metastases in High Risk Prostate Cancer Cases